Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Frediani

Showing results (261-270 of 336) with videos related to

Pageof 34
Sort By:
Ophthalmology and Therapy|November 4, 2023
Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA NetworkCarla Gaggiano, Vishali Gupta, Rupesh Agrawal, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre studyGiacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
Rheumatology International|June 5, 2026
Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
Frontiers in Medicine|October 2, 2024
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis RegistryAntonio Vitale, Valeria Caggiano, Eduardo Martín-Nares, et al.
Rheumatology (Oxford, England)|May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA RegistryJurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease|September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA NetworkCarla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Frontiers in Medicine|January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registryAntonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Frontiers in Medicine|July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA NetworkAntonio Vitale, Laura Obici, Marco Cattalini, et al.
Pageof 34

Showing results (261-270 of 336) with videos related to

Sort By:
Pageof 34
Ophthalmology and Therapy|November 4, 2023
Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA NetworkCarla Gaggiano, Vishali Gupta, Rupesh Agrawal, et al.
Clinical and Experimental Rheumatology|December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre studyGiacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
Rheumatology International|June 5, 2026
Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
Frontiers in Medicine|October 2, 2024
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis RegistryAntonio Vitale, Valeria Caggiano, Eduardo Martín-Nares, et al.
Rheumatology (Oxford, England)|May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA RegistryJurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease|September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA NetworkCarla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Clinical and Experimental Rheumatology|October 6, 2022
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for RheumatologyAndreina Manfredi, Giulia Cassone, Raffaella Izzo, et al.
Frontiers in Medicine|January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registryAntonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Therapeutic Advances in Musculoskeletal Disease|February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA RegistryGiuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Frontiers in Medicine|July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA NetworkAntonio Vitale, Laura Obici, Marco Cattalini, et al.
Pageof 34